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A liquid chromatography–high resolution mass spectrometry (LC–HRMS) method was developed and
validated for the determination of piperine (PPR) on dried blood spots (DBS). DBS samples were prepared
by spiking the whole blood with analyte to produce 30 mL of blood spots on specimen collection cards.
Chromatographic separation was achieved on an Atlantis dC18 column using acetonitrile and water (0.1%
formic acid) (85:15, v/v) as mobile phase in an isocratic mode of elution at a ﬂow rate of 0.75 mL/min. MS
detection was carried out in electrospray positive ion mode for the target ions and monitored at m/z
286.1465 for PPR and 272.1303 for the internal standard (IS). The developed method exhibited a linear
dynamic range over 0.01–2000 ng/mL for PPR on DBS. The overall extraction recovery of PPR from DBS
was 92.5%. Inﬂuence of hematocrit and spot volume on DBS was also evaluated and found to be well
within the acceptable limits. The method was successfully applied to pharmacokinetic studies of PPR in
rats.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Piperine (PPR), a major alkaloid of Piper longum and Piper ni-
grum, has been reported to have several pharmacological actions.
It exhibits antioxidant, anti-inﬂammatory, antidiarrheal, anti-
convulsant, antimutagenic, hypolipidemic, bile secretion-promoting
and tumor-inhibiting activities [1,2]. It is also a known anti-
depressant of the central nervous system [3,4]. In addition, it has
been reported to enhance the bioavailability of several drugs [5,6].
Because of these multiple biological effects, bioanalysis and
pharmacokinetic studies of PPR have become a focus of research.
Several analytical methods were reported in the literature for the
determination of PPR alone or in combination with other bioactive
compounds in biological ﬂuids, including high performance thin
layer chromatography (HPTLC) [7], high performance liquid chro-
matography (HPLC) [8,9], liquid chromatography–nuclear mag-
netic resonance–mass spectrometry (LC–NMR–MS) [10], liquid
chromatography–tandem mass spectroscopy (LC–MS/MS) [11,12]
and ultra-fast liquid chromatography (UFLC) [13,14]. In all the
above methods, sample treatment has been carried out by proteinon and hosting by Elsevier B.V. All
University.
u),precipitation. However, these assays require a relatively large
blood volume (typically 40.5 mL) to generate sufﬁcient plasma
volume for analysis. In contrast, dried blood spots (DBS), the col-
lection of blood samples on absorbent paper requires minimum
blood volumes, which can easily be obtained by ﬁnger or heel
prick, and obviates plasma centrifugation to simplify sample pre-
paration. Compared with conventional whole blood samples, the
collection of whole blood samples on ﬁlter paper shows distinct
advantages, including longer lifespan of samples with reduced
need for refrigeration, less invasiveness, greater cost-effectiveness,
easy shipment and storage, and reduction of infection risks by
deactivation of potential pathogens on the ﬁlter paper.
Thus, DBS has become a subject of interest for the quantiﬁcation
of various drugs for pharmacokinetic studies as the bioanalytical dry
matrix offers several advantages over conventional venous blood
sampling. This also facilitates signiﬁcant advantages when ethical
considerations hamper large volume sampling in premature infants
and the elderly. Also, a number of publications on the use of DBS for
the analysis of a variety of drugs including antimalarials [15], anti-
epileptics [16], antiretrovirals [17], antidiabetics [18] and anti-
hypertensives [19] have been reported. The successful usage of DBS
has also been reported in toxicokinetic [20], therapeutic drug
monitoring [21] and pharmacokinetics studies [22] as well.
To the best of our knowledge, no studies have been reported for
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extracts which are used in ayurvedic formulation usually contain
very minute amount of bioactive compounds. It is also common
that these extracts may contain a number of molecules which
sometimes have the same molecular weight. In the present study,
we employed high–resolution mass spectrometry (HRMS) because
it offers high sensitivity, mass resolution and mass accuracy
(o5 ppm). HRMS in general has been improved over the last
couple of years and is now competitive with triple quadrupole MS
for quantitation. Here, we described the details of our attempts to
develop and validate a simple, sensitive and selective LC–HRMS
method for the quantiﬁcation of PPR on DBS and discussed its
potential utility.2. Experimental
2.1. Chemicals and materials
PPR and trichostachine (TCS) were isolated from Piper nigrum
fruits in our laboratory. Their structures were identiﬁed by NMR
and MS analysis and compared with reported data [23]. HPLC
grade methanol, acetonitrile and formic acid were obtained from
Merck Specialties Pvt. Ltd. (Mumbai, India). Water used in the
entire analysis was prepared on a Milli–Q water puriﬁcation sys-
tem procured from Millipore (Bangalore, India). FTA DMPK-C cards
were supplied by Whatmann (Whatman, GE Healthcare, NJ).
Sample tubes were obtained from Tarsons (Kolkata, India). A
centrifuge (model 2–16P) supplied by Sigma (Zurich, Switzerland)
and a Harris punch and cutting mat supplied by Whatmann
(Stanford, ME, USA) were employed. Sachets of silica gel and
sealing plastic bags for the storage of blood spot cards were pur-
chased from the local market. The repeater multi pipette used for
spotting blood was obtained from Tarsons (Kolkata, India). EDTA
coated capillaries from Sarstedt (Leicester, UK) were used.
2.2. Liquid chromatography–high resolution mass spectrometry (LC–
HRMS)
The chromatographic system consisting of an Agilent 1200
series LC instrument (Agilent Technologies, USA) coupled with
quadrupole time–of–ﬂight (Q–TOF) mass spectrometer (Q–TOF LC/
MS 6510 series classic G6510A, Agilent Technologies, USA) equip-
ped with an ESI source was used. Chromatography was performed
on Waters Atlantis dC18 (150 mm4.6 mm, 5 μm) column at 25 °CFig. 1. Extraction of PPR frusing acetonitrile and water (containing 0.1% formic acid) (85:15,
v/v) as mobile phase in an isocratic elution mode at a ﬂow rate of
0.75 mL/min, and the injection volume was 10 mL. The data ac-
quisition was under the control of Mass Hunter workstation soft-
ware. The typical operating source conditions for MS scan in po-
sitive ESI mode were optimized: the ionization voltage 80 V, the
capillary voltage 3000–3500 V, the skimmer 60 V, nitrogen used
as the drying (300 °C; 9 L/min) and nebulizer (45 psi) gas. External
calibration of the TOF–MS was performed daily before the analysis.
2.3. Preparation of stock solutions, calibration standards (CSs) and
quality control (QC) samples
PPR and internal standard (IS) (approximately 10 mg) were
dissolved in 10 mL of methanol in a volumetric ﬂask to give a
1 mg/mL stock solution. Working solutions containing all analytes
were freshly prepared in methanol : water (50:50, v/v) to produce
dilutions of 20,000, 15,000, 10,000, 5000, 2500, 1000, 500, 250,
100, 20 and 0.1 ng/mL. CSs were prepared by spiking different
samples of fresh blood (900 mL) with 100 mL of each of the above-
mentioned working solutions to yield ﬁnal concentrations of 2000,
1500, 1000, 500, 250, 100, 50, 25, 10, 2 and 0.01 ng/mL of PPR in
the blood. A zero PPR blood sample (blank) was prepared by
spiking fresh blood (900 mL) with 100 mL of methanol : water
(50:50, v/v). QC samples were prepared by diluting the appro-
priate working standards with whole blood to give concentrations
of 10 (low QC), 400 (medium QC) and 1200 (high QC) ng/mL of
PPR. QC and CS samples thus prepared were employed for use in
the validation of the method and also for stability studies. These
DBS QCs were stored at room temperature in sealed plastic bag
containing desiccant for further use.
2.4. DBS sample preparation
Using a calibrated pipette, 30 mL of the respective whole blood
samples collected at regular intervals was spotted onto FTA blood
spot cards to prepare the DBS samples. The samples were set to
dry for 3 h at room temperature and stored at 4 °C until required
for analysis.
2.5. DBS sample extraction
A 10 mm disk was punched from the center of the DBS sample
and transferred to a microcentrifuge tube. A 500 mL volume of
extraction solvent (50% aqueous methanol) consisting of ISom dried blood spots.
B. Ramesh et al. / Journal of Pharmaceutical Analysis 6 (2016) 18–2320(250 ng/mL) was added, and the tube was vortex mixed for 10 min.
The contents were centrifuged for 10 min, and the supernatant
was transferred to an autosampler vial for analysis by LC–HRMS.
The extraction procedure is shown schematically in Fig. 1.
2.6. Validation procedures
Validation of the developed method was performed to evaluate
the following parameters: selectivity, linearity, precision, accuracy,
lower limit of quantiﬁcation (LLOQ) as well as stability of QC
samples. DBS also has its own unique set of properties that should
be assessed, which include spot volume, hematocrit and dilution
effects [24].Fig. 3. ESI–HRMS spectra of (A) PPR and (B) IS.3. Results and discussion
3.1. Selection of IS
Selection of appropriate IS is an important aspect to deal with
sample matrix effects. An ideal IS should be a structurally similar
analog or stable isotope–labeled compound. TCS was chosen as the
IS for the quantiﬁcation of PPR due to its similarity in structure
(Fig. 2), ionization response and extraction recovery in ESI–MS and
a similar elution pattern.
3.2. Optimization of chromatographic conditions
Chromatographic conditions, especially the composition of
mobile phase, play a critical role in achieving good chromato-
graphic behavior and appropriate ionization. Different mobile
phases (methanol–water, acetonitrile–water with or without for-
mic acid or ammonium acetate) were investigated using Atlantis
dC18 (150 mm4.6 mm, 5 mm) column to optimize the analytical
performance. It was observed that acetonitrile was found to be
better in terms of resolution and peak shapes as compared with
methanol. Using acetonitrile–water (containing 0.1% formic acid)
good peak shape, considerable response and baseline separation
were achieved. The mobile phase was operated at a ﬂow rate of
0.75 mL/min allowing a short run time of 3.0 min, without com-
promising the chromatographic selectivity.
3.3. Optimization of mass conditions
MS parameters were tuned in positive ionization mode for PPR
and the IS. The MS parameters were optimized to maximize the
response. Acetonitrile offered a higher response than methanol
and was therefore chosen as the organic modiﬁer in the eluent.
Addition of 0.1% formic acid to the mobile phase increased MS
response. Since extracted ion chromatograms (EICs), based on the
accurate mass measurement, were to be used for quantiﬁcation of
PPR, it was necessary to determine the accurate masses of the
analyte and the IS. Standard mass spectra in the full scan range of
m/z 100–1000 were obtained by injecting standard solutions of
PPR (500 ng/mL) and the IS (250 ng/mL). The molecular ions
[MþH]þ for PPR and the IS showed a high intensity signal at m/z
286.1465 and m/z 272.1303 (Fig.3), respectively. The mass devia-
tion observed was 4.94 ppm for PPR and 3.81 ppm for the IS.Fig. 2. Chemical structures of (A) PPR and (B) IS.3.4. Optimization of sample preparation
In the present work, different extraction solvents were in-
vestigated for extraction of PPR and the IS from DBS. Spiked DBSs
were treated with different solvents and mixtures (methanol,
acetonitrile, buffer/organic solvent mixtures): pure organic sol-
vents were proved to be unsuitable for removing PPR from the
paper (extraction yields less than 50%), whereas addition of aqu-
eous solvent (water) increased extraction of the analyte from DBS
samples. Finally, a mixture of methanol/water (50:50, v/v) gave
promising results in terms of sample cleaning and extraction
yields (more than 90%).
3.5. Method validation
3.5.1. Linearity, selectivity and LLOQ
The peak area ratio of PPR to the IS in DBS sample was linear
with respect to the analyte concentration over the range of 0.01–
2000 ng/mL. The mean linear regression equation of calibration
curve for the analyte was y¼758.2x þ0.091, where y is the peak
area ratio of the analyte to the IS and x is the concentration of the
analyte. The correlation coefﬁcient (r2) for PPR was 0.9987 over
the concentration range used. The LLOQ, the lowest concentration
of the standard curve that can be measured with acceptable ac-
curacy and precision for the analyte from the normal DBS sample,
was 0.01 ng/mL. To demonstrate the selectivity of the LC–HRMS
Fig. 4. Representative LC–MS chromatograms of (A) a blank DBS and DBS samples
spiked with IS and PPR at (B) LLOQ, (C) higher limit of quantiﬁcation (HLOQ) and
(D) 4.0 h after administration of a 15 mg/kg oral dose of PPR.
Table 2
The recovery and matrix effect of PPR and the IS (n¼6).
Analyte Conc. added (ng /mL) Recovery (%) Matrix effect (%)
Mean7SD RSD Mean7SD RSD
PPR 10 93.1571.25 1.34 96.3773.02 3.13
400 92.6472.34 2.52 95.0771.87 1.96
1200 92.8172.14 2.30 93.9272.33 2.48
IS 50 94.5471.73 1.82 93.187 .1.26 1.35
Table 3
Stability of PPR in rat plasma (n¼6).
Stability
tested
Conc. added
(ng/mL)
Conc. found
(Mean7SD)
(ng/mL)
Precision
(RSD, %)
Accuracy
(RE, %)
At 25 °C for
24 h
10 9.7870.44 4.49 2.20
400 402.5671.98 0.49 0.64
1200 1195.6973.21 0.26 0.43
At 4 °C for
7 days
10 10.3570.38 3.67 3.50
400 397.2172.56 0.64 0.69
1200 1204.2772.84 0.23 0.35
At 20 ºC
for 30
days
10 9.8170.41 4.17 1.90
400 405.2371.58 0.38 1.30
1200 1198.0773.74 0.31 0.16
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analyzed and subsequently processed. No interferences were ob-
served at the retention time of PPR and the IS in any of the sam-
ples (Fig. 4).
3.5.2. Accuracy and precision
Intra-day assay precision and accuracy were calculated using
six determinations of the three DBS QCs during a single analytical
run. Inter-day assay precision and accuracy were evaluated by
analyzing the six QCs once a day for three consecutive days. The
precision and accuracy were presented as RSD (%) and RE (%), re-
spectively. All values obtained were well within acceptance criteria
for assay validations and were within the pre-deﬁned 15% limits
required. The data of intra-day and inter-day accuracy and preci-
sion of the method are summarized in Table 1.
3.5.3. Recovery and matrix effect
The extraction recoveries of PPR and the IS were determined by
comparing the peak areas of extracted QC samples (n¼6) with the
peak areas of pure QC samples of the same concentrations. The
recoveries of PPR and the IS were determined at three con-
centration levels of QC (low, medium and high concentrations) as
given in Table 2. The matrix effect was evaluated by comparing the
chromatographic peak areas of neat solutions of the analyte and
the IS spiked into extracted blank DBS samples (n¼6) at low,
medium and high concentration levels with those of the standard
solutions at the same concentrations. The results were consistent
over the tested concentration levels and found to be within ac-
ceptable limits (95%–105%). Thus, the matrix effects were found to
be insigniﬁcant and did not affect the accuracy of the proposedTable 1
Intra-day and inter-day precision and accuracy for the detection of PPR in rat plasma (n
Analyte Conc. added
(ng/mL)
Intra-day
Conc. found (Mean7SD)
(ng/mL)
Precision
(RSD, %)
10 10.2170.16 1.56
Rat-DBS 400 398.1171.84 0.46
1200 1203.41710.36 0.86LC–HRMS method.
3.5.4. Stability
The results obtained from stability studies indicated that PPR
DBSs at three concentration levels in six replicates were stable at
ambient temperature (25 °C) for 24 h. Again the long-term stabi-
lity studies of the sample at 4 °C for 7 days and also at 20 °C for
30 days did not alter the analyte. The stability test results are given
in Table 3. It can be seen from Table 3 that the results were well
within the acceptance limits.
3.6. Blood spot size
The effect of blood spot volume was assessed at two QC levels
of 100 and 500 ng/mL in replicate (n¼5) at various spot volumes
(25, 30 and 35 mL) spotted on DBS cards. A 10 mm diameter disk
was punched from the center of each sample to avoid possible
problems arising from punch location, and the samples were
subsequently extracted. Concentrations assessed from each spot
were compared with the standard spot volumes, and a linear re-
gression equation was generated from 30 mL of DBS samples. The
accuracy and precision data were within the 15% limit for 25 and
35 mL spot volume sizes at the two tested concentrations (Table 4),
indicating that the amount of blood spotted did not affect the
distribution of PPR across the FTA card for quantiﬁcation.¼6).
Inter-day
Accuracy
(RE, %)
Conc. found (Mean7SD)
(ng/mL)
Precision
(RSD, %)
Accuracy
(RE, %)
2.1 10.3570.21 2.02 3.5
0.47 403.2772.28 0.56 0.81
0.28 1197.48711.27 0.94 0.21
Table 4
Effect of varying blood spot size on accuracy and precision of assay of PPR.
PPR concentration
in whole blood
(ng/mL)
DBS vo-
lume (mL)
Conc. found (mean
7SD) (ng/mL)
(n¼6)
Accuracy
(RE, %)
Precision
(RSD, %)
100 25 97.2872.35 2.72 2.41
30 97.9172.81 2.09 2.86
35 98.5772.73 1.43 2.76
500 25 503.5473.17 0.70 0.62
30 496.5974.72 0.68 0.95
35 498.2775.24 0.34 1.05
Fig. 5. Mean plasma concentration–time proﬁle of PPR after administration of an
oral dose of 15 mg/kg of PPR to male Wistar rats (Data are expressed as mean7SD
(n¼6)).
Table 6
Pharmacokinetic parameters of PPR after oral administration at a dose of 50 mg/kg
to rats (n¼6).
Pharmacokinetic parameters DBS (Mean7SD) Plasma (Mean7SD)
Cmax (ng/mL) 1454784 16597147
Tmax (h) 0.77 0.3 0.57 0.4
t1/2 (h) 2.870.5 2.670.2
AUC0 t (ng h/mL) 49317196 56887449
AUC01 (ng h/mL) 48647238 56997448
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It is necessary to test the effect of hematocrit (Hct) on the de-
termination of active analytes in the blood. Hct has a signiﬁcant
effect on blood viscosity. Variability in viscosity leads to differences
in ﬂux and diffusion properties of blood through the DBS card used
for sample collection. This can directly affect the accuracy of de-
terminations of analytes in DBS samples. Hct is normally about
0.31–0.50 for rats [25]. At a high Hct value, the distribution of blood
sample through the paper/card might be poor, resulting in a smaller
blood spot when compared with the blood sample with a low Hct.
The effects of 20%, 35% and 50% Hct were tested with 10 mm spot
size at 1000 ng/mL of PPR. The measured PPR concentrations were
compared with the results obtained from DBS samples with Hct of
35%, and the results are given in Table 5. The results revealed that %
RSD was within the acceptance criteria irrespective of Hct values.
3.8. Animal experiments
The applicability of the developed bioanalytical method (LC–
HRMS) for PPR in DBS was demonstrated by the results obtained
from pharmacokinetic studies conducted in six male Wistar rats
weighing 200720 g approximately which were fasted overnight
before and 4 h after PPR dosing (The study was approved by the
Animal Ethical Committee of Indian Institute of Chemical Tech-
nology, Hyderabad). Each rat received an oral dose of 15 mg/kg of
PPR in 50% propylene glycol/50% Milli Q water (v/v) formulation at
a concentration of 1 mg/mL of PPR. Blood samples (30 mL) were
collected from prick from the tail. Serial blood samples were
spotted onto the FTA bloodspot cards at 0, 0.5, 1, 2, 3, 4, 5, 6, 8, 10,
12 and 24 h post-dose. The samples were processed, as per the
procedure detailed in Section 2.5, and analyzed.
3.9. Pharmacokinetics
The mean concentration–time data were subjected to non-
compartmental pharmacokinetic analysis using linear trapezoidal
rule. Fig. 5 shows the mean plasma concentration–time proﬁle of
PPR. The pharmacokinetic parameters such as Cmax, Tmax, t1/2, AUC0 t
and AUC0–1 for PPR are summarized in Table 6. The pharmacokinetic
data obtained from DBS were further compared with that fromTable 5
Inﬂuence of hematocrit value on precision and accuracy of the assay of PPR
(1000 ng/mL).
Parameters Hematocrit (%)
20 35 50
Mean concentration (ng/mL) 975.21 984.37 992.07
SD 8.35 6.54 4.51
Precision (RSD, %) 0.85 0.66 0.45
Accuracy (RE, %) 2.47 1.56 0.79
Percent difference from 35% Hct 0.91 0 0.77earlier reports for PPR using a conventional biomatrix i.e., plasma
[12]. The data obtained in this investigation were in very close
agreement, thus conﬁrming the validity of the DBS method.4. Conclusion
We demonstrated that a full scan LC–HRMS assay met the va-
lidation acceptance criteria in terms of accuracy, precision, se-
lectivity, sensitivity and matrix effect. The LC–HRMS method de-
veloped was rapid and provided high-sensitivity determination of
PPR in DBS samples. The developed DBS method has several ad-
vantages such as non-invasive, requiring only a micro-volume
blood sample (typically r50 mL) and simple to perform compared
with conventional venous blood sampling. The fully validated LC–
HRMS method is simple, highly sensitive, speciﬁc, robust, and has
been successfully applied to pharmacokinetic study in rat DBS.Acknowledgments
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